Featured Firms
Presented by BigVoodoo
Bristol-Myers Squibb has agreed to pay $670 million to settle two antitrust lawsuits related to marketing of two generic drugs. In December 2001, 29 states and Puerto Rico sued Bristol-Myers, claiming it used illegal tactics to keep a generic version of the anti-anxiety drug BuSpar off the market. Last June, a different group of 29 states accused the company of illegally blocking a generic version of its cancer drug Taxol.
January 08, 2003 at 12:00 AM
1 minute read
The original version of this story was published on Law.Com
Presented by BigVoodoo
The premier educational and networking event for employee benefits brokers and agents.
The Legal Intelligencer honors lawyers leaving a mark on the legal community in Pennsylvania and Delaware.
Consulting Magazine recognizes leaders in technology across three categories Leadership, Client Service and Innovation.
Atlanta s John Marshall Law School is seeking to hire one or more full-time, visiting Legal WritingInstructors to teach Legal Research, Anal...
Shipman is seeking an associate to join our Labor & Employment practice in our Hartford, New Haven, or Stamford office. Candidates shou...
Evergreen Trading is a media investment firm headquartered in NYC. We help brands achieve their goals by leveraging their unwanted assets to...
MELICK & PORTER, LLP PROMOTES CONNECTICUT PARTNERS HOLLY ROGERS, STEVEN BANKS, and ALEXANDER AHRENS